Bivalent molecules comprising dual functional motifs often exhibit strong target binding, however arriving at the optimal structure is challenging. Here, the authors employ EGFR as a model system for understanding a subtle difference in the linker structure of bivalent inhibitors to enhance binding against drug-resistant EGFR mutants.
- Florian Wittlinger
- Blessing C. Ogboo
- David E. Heppner
